Literature DB >> 20413684

Pathogenesis of middle ear cholesteatoma: a new model of experimentally induced cholesteatoma in Mongolian gerbils.

Tomomi Yamamoto-Fukuda1, Yoshitaka Hishikawa, Yasuaki Shibata, Toshimitsu Kobayashi, Haruo Takahashi, Takehiko Koji.   

Abstract

Middle ear cholesteatoma is characterized by enhanced proliferation of epithelial cells with aberrant morphological characteristics. To investigate the origin of the cholesteatoma cells, we analyzed spontaneously occurring cholesteatomas associated with a new transplantation model in Mongolian gerbils (gerbils). Cholesteatomas were induced in gerbils with a transplanted tympanic membrane by using the external auditory canal (EAC) ligation method. After the pars flaccida of the tympanic membranes were completely removed from male gerbils, corresponding portions of tympanic membranes of female gerbils were transplanted to the area of defect, and then we ligated the EAC (hybrid-model group). As a control group, the EAC of normal male and female gerbils was ligated without myringoplasty. In all ears of each group, the induced cholesteatomas were seen. In situ PCR was then performed to detect the mouse X chromosome-linked phosphoglycerate kinase-1 (pgk-1) gene on the paraffin sections. One pgk-1 spot in the epithelial nuclei was detected in male cholesteatoma, and two pgk-1 spots were detected in female cholesteatoma, respectively. On the other hand, in the hybrid-model group, we detected not only one but also two pgk-1 spots in the epithelial nuclei of cholesteatoma. These results strengthened the evidence that the origin of epithelial cells in cholesteatoma is the tympanic membrane in this model, but not the residential middle ear epithelial cells or the skin of the EAC.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20413684      PMCID: PMC2877823          DOI: 10.2353/ajpath.2010.091182

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  17 in total

1.  Incidence, etiology and pathogenesis of cholesteatoma in children.

Authors:  M Tos
Journal:  Adv Otorhinolaryngol       Date:  1988

2.  Pathogenesis and surgical treatment of the middle ear cholesteatoma.

Authors:  L Rüedi
Journal:  Acta Otolaryngol Suppl       Date:  1979

3.  [Expression and activation of nuclear factor-kappaB in middle ear cholesteatoma].

Authors:  Yu Xu; Ze-zhang Tao; Qing-quan Hua; Xin-xhun Wang; Bo-kui Xiao
Journal:  Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi       Date:  2006-06

4.  Comparative cytokeratin distribution patterns in cholesteatoma epithelium.

Authors:  E Olszewska; H Sudhoff
Journal:  Histol Histopathol       Date:  2007-01       Impact factor: 2.303

5.  Experimental retraction pocket cholesteatoma.

Authors:  D E Wolfman; R A Chole
Journal:  Ann Otol Rhinol Laryngol       Date:  1986 Nov-Dec       Impact factor: 1.547

6.  Improvement of in situ PCR by optimization of PCR cycle number and proteinase k concentration: localization of x chromosome-linked phosphoglycerate kinase-1 gene in mouse reproductive organs.

Authors:  Yoshitaka Hishikawa; Shucai An; Tomomi Yamamoto-Fukuda; Yasuaki Shibata; Takehiko Koji
Journal:  Acta Histochem Cytochem       Date:  2009-04-23       Impact factor: 1.938

7.  Cholesteatoma. Experimental induction in the Mongolian Gerbil, Meriones Unguiculaus.

Authors:  M D McGinn; R A Chole; K R Henry
Journal:  Acta Otolaryngol       Date:  1982 Jan-Feb       Impact factor: 1.494

8.  Parental imprinting studied by allele-specific primer extension after PCR: paternal X chromosome-linked genes are transcribed prior to preferential paternal X chromosome inactivation.

Authors:  J Singer-Sam; V Chapman; J M LeBon; A D Riggs
Journal:  Proc Natl Acad Sci U S A       Date:  1992-11-01       Impact factor: 11.205

9.  Cloning and expression of the mouse pgk-1 gene and the nucleotide sequence of its promoter.

Authors:  C N Adra; P H Boer; M W McBurney
Journal:  Gene       Date:  1987       Impact factor: 3.688

Review 10.  Surgical techniques and recidivism in cholesteatoma.

Authors:  D R Edelstein; S C Parisier
Journal:  Otolaryngol Clin North Am       Date:  1989-10       Impact factor: 3.346

View more
  8 in total

1.  Regulation of DNA methylation levels in the process of oral mucosal regeneration in a rat oral ulcer model.

Authors:  Naotaro Akiyama; Tomomi Yamamoto-Fukuda; Mamoru Yoshikawa; Hiromi Kojima
Journal:  Histol Histopathol       Date:  2019-07-09       Impact factor: 2.303

2.  Surgical treatment of middle ear cholesteatoma using an oral approach in 2 dogs.

Authors:  Kae Shigihara; Naoko Yayoshi; Harumi Sawada; Yutaka Momota; Yasushi Hara
Journal:  Can Vet J       Date:  2022-04       Impact factor: 1.075

Review 3.  Animal models of middle ear cholesteatoma.

Authors:  Tomomi Yamamoto-Fukuda; Haruo Takahashi; Takehiko Koji
Journal:  J Biomed Biotechnol       Date:  2011-04-06

Review 4.  Development of animal models of otitis media.

Authors:  Moo Kyun Park; Byung Don Lee
Journal:  Korean J Audiol       Date:  2013-04-16

5.  Bilateral tympanokeratomas (cholesteatomas) with bilateral otitis media, unilateral otitis interna and acoustic neuritis in a dog.

Authors:  Liv Østevik; Kathrine Rudlang; Tuva Holt Jahr; Mette Valheim; Bradley Lyndon Njaa
Journal:  Acta Vet Scand       Date:  2018-05-22       Impact factor: 1.695

6.  Engineered oncolytic virus for the treatment of cholesteatoma: A pilot in vivo study.

Authors:  Ravi N Samy; Brian R Earl; Noga Lipschitz; Ivy Schweinzger; Mark Currier; Timothy Cripe
Journal:  Laryngoscope Investig Otolaryngol       Date:  2019-10-15

7.  Cholesteatoma in a cat.

Authors:  Akash Alexander; Paul Mahoney; Emma Scurrell; Stephen Baines
Journal:  JFMS Open Rep       Date:  2019-05-10

8.  In situ tissue engineering with synthetic self-assembling peptide nanofiber scaffolds, PuraMatrix, for mucosal regeneration in the rat middle-ear.

Authors:  Naotaro Akiyama; Tomomi Yamamoto-Fukuda; Haruo Takahashi; Takehiko Koji
Journal:  Int J Nanomedicine       Date:  2013-07-24
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.